Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Urology-Nephrology
»
Neoplasia/BPH
19. January 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Anzeige
Zoom:
Page 1 of 9238
Articles 1 - 20 / 184754
Development and external validation of a nomogram predicting cancer-specific mortality-free survival after trimodal therapy in muscle-invasive bladder cancer.
World J Urol
Longoni M, Falkenbach F, Marmiroli A, Le QC, Nicolazzini M, Catanzaro C, Polverino F, Goyal JA, Graefen M, Ferro M, Chun FKH, Palumbo C, Schiavina R, Longo N, Saad F, Shariat SF, Moschini M, Gandaglia G, Montorsi F, Briganti A, Karakiewicz PI.
PMID: 41553578 [PubMed - indexed for MEDLINE]
Added value of synthetic MRI in refining biparametric MRI VI-RADS for predicting muscle-invasive bladder cancer.
Abdom Radiol (NY)
Zhao Z, Zhao Z, Bu X, Wang M, Zhao T, Fu L, Cui Y, Jiang Y, Yang W, Xu J, Peng XG.
PMID: 41553526 [PubMed - as supplied by publisher]
Efficacy of a pubic superior ramus approach versus a distal approach for obturator nerve block in transurethral bladder tumor resection: a randomized controlled trial.
Am J Transl Res
Zhang J, Wei J, Han L.
PMID: 41552287 [PubMed]
Integrated Boost vs. Sequential Scheme in Volumetric Modulated Arc Therapy (VMAT) for Trimodal Bladder Cancer Therapy: A Comparative Study.
Cureus
El Mjabber R, Alami R, Aouzah F, Bezzari W, Dahbi Z, Kouhen F, Ismaili N, El Majjaoui S, Naim A.
PMID: 41552059 [PubMed]
Correction: Attitudes and intentions toward prostate cancer screening among males in China: a qualitative study.
Front Urol
Hao S, Fang L, Du Y, Zheng J, Ou Y, Yu Z.
PMID: 41551753 [PubMed]
Rare renal metastasis: Oligometastatic non-small cell lung cancer diagnosed with ultrasound guided renal biopsy.
Radiol Case Rep
Neerhut T, McMaster T, Homewood D, Bray G, Wilson R, Buzacott K, Attwell-Heap A.
PMID: 41551102 [PubMed]
Interdisciplinary Swiss consensus recommendations for follow-up after radical cystectomy and trimodal treatment for muscle-invasive bladder cancer.
Bladder Cancer
Kaufmann E, Aeppli S, Affentranger A, Arnold N, Arnold W, Aschwanden F, Balermpas P, Beyer J, Bieri U, Boormanns J, Cathomas R, Bari B, Dressler M, Engeler DS, Erdmann A, Gallina A, Gomez S, Guckenberger M, Herrmann T, Hermanns T, Lucca I, John H, Kessler TM, Klein J, Laouiti M, Lauffer D, Lerner SP, Mattei A, Müntener M, Nguyen D, Niederberger P, Papachristofilou A, Prause L, Putora PM, Reinhardt K, Salati E, Sèbe P, Shelan M, Sigg S, Strebel RT, Templeton AJ, Vogl U, Wettstein MS, Wyler S, Zihler D, Zilli T, Zwahlen D, Roth B, Fankhauser CD.
PMID: 41550985 [PubMed]
PARP Inhibitor Olaparib and Its Combination Therapy in Metastatic Castration-resistant Prostate Cancer: A Systematic Review and Network Meta-analysis.
Eur Urol Open Sci
Li Y, Li Z, Lu H, Shi P, Liu Y, Liu L, Chen K.
PMID: 41550797 [PubMed]
Noninvasive Early Detection and Recurrence Monitoring for Non-Muscle-Invasive Bladder Cancer via Urine Tumor DNA: A Prospective Clinical Study.
MedComm (2020)
Wu J, Jin S, Bai Q, Wang H, Cheng H, Zhou X, Shen Y, Ma C, Gu C, Chen H, Zhang Y, Chen L, Shariat SF, Lou F, Cao S, Zhu Y, Ye D.
PMID: 41550467 [PubMed]
Exercise, nutrition, and psychological support for kidney cancer: a scoping review.
BJU Int
Briggs LG, Parke SC, Gill VS, Van Ligten MJ, Beck KL, Sinha D, Alkhatib KY, Choudry MM, Bain PA, Quillen J, Dodoo CA, Pierorazio P, Abdul-Muhsin H, Andrews PE, Trinh QD, Psutka SP.
PMID: 41549535 [PubMed - as supplied by publisher]
Interpretable machine learning using CT radiomics predicts pathological upgrading after secondary resection in non-muscle-invasive bladder cancer.
BMC Cancer
Rao XP, Zou XC, Yu ZJ, Yuan YY, Chao HC, Huang JB, Zeng T.
PMID: 41549273 [PubMed - as supplied by publisher]
Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 Trial.
Eur Urol
Nagumo Y, Kimura T, Ishikawa H, Sekino Y, Maruo K, Mathis BJ, Kageyama Y, Ushijima H, Kamei J, Yamashita H, Azuma H, Nihei K, Naiki T, Tomita N, Kobayashi Y, Yoshio K, Matsumoto T, Yoshitake T, Osawa T, Nishioka K, Kita Y, Mizowaki T, Hattori K, Tsuzuki T, Hashimoto K, Nishiyama H.
PMID: 41548990 [PubMed - as supplied by publisher]
Targeting glycolysis in prostate cancer: Molecular mechanisms and therapeutic advances.
Biochim Biophys Acta Rev Cancer
Zhang J, Zhang T, Song D, Xu D.
PMID: 41548699 [PubMed - as supplied by publisher]
Cellular signaling and radioresistance in prostate cancer.
Cell Signal
Sosa GA, Crosswhite B, Kirschner AN.
PMID: 41548628 [PubMed - as supplied by publisher]
Adjuvant bacillus Calmette-Guérin (BCG) immunotherapy versus BCG combined with disitamab vedotin in BCG-naïve high-risk non-muscle invasive bladder cancer with HER2 expression: A real-world study.
Int Immunopharmacol
Xu T, Wang K, Chen Y, Yu Y, Zhang W, Shen D, Zhang J, Geng J, Peng B, Yan Y, Yao X.
PMID: 41548434 [PubMed - as supplied by publisher]
Two Versus Five-Fraction Magnetic Resonance-Guided Adaptive Radiotherapy with DOminant-TArgeted Boost in Localized Prostate Cancer (DOTA-2): Interim Acute Toxicity Analysis of the Phase II Randomised Trial.
Clin Oncol (R Coll Radiol)
Romrattaphan R, Dankulchai P, Prasartseree T, Sittiwong W, Thaweerat W, Junlabut S, Nitipitch S.
PMID: 41548387 [PubMed - as supplied by publisher]
Current landscape and therapeutic prospects of indole hybrids for prostate cancer treatment: A mini-review.
Eur J Med Chem
Xu Z, Shi Y, Pan B, Wang H.
PMID: 41548295 [PubMed - as supplied by publisher]
Prognostic Impact of Initial Prostate Specific Antigen Half-Life After Abiraterone Acetate in High-Volume Metastatic Hormone-Sensitive Prostate Cancer: Who May Need Triplet Therapy?
Prostate
Suzuki K, Ueki H, Wakita N, Okamura Y, Bando Y, Hara T, Terakawa T, Hyodo Y, Chiba K, Teishima J, Miyake H.
PMID: 41548191 [PubMed - as supplied by publisher]
Clinical hurdles for curcumin and piperine nanoparticles in prostate cancer treatment: a bridge too far or a path to clinical reality?
Expert Opin Drug Deliv
Yakubu J, Tagit O, Pandey AV.
PMID: 41548083 [PubMed - as supplied by publisher]
IRF7 is a novel prognostic biomarker in kidney renal clear cell carcinoma.
Sci Rep
Fu S, Zhou W, Yin W, Chen Y, Cao L, Chen Y, Xiao Z.
PMID: 41547907 [PubMed - as supplied by publisher]
Articles 1 - 20 / 184754
Page 1 of 9238
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy